Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
Link to record
Permanent link

Direct link
Publications (10 of 35) Show all publications
Gries, A., Kumar, K. S., Kuttler, F., Özalp, Ö., Akle, V., Zhang, H., . . . Baumgartner, M. (2025). Aurora kinase B is required for growth and expansion of medulloblastoma cells in the tissue context. Neoplasia, 59, Article ID 101078.
Open this publication in new window or tab >>Aurora kinase B is required for growth and expansion of medulloblastoma cells in the tissue context
Show others...
2025 (English)In: Neoplasia, ISSN 1522-8002, E-ISSN 1476-5586, Vol. 59, article id 101078Article in journal (Refereed) Published
Abstract [en]

The impact of the tissue context on tumor growth and drug response in medulloblastoma (MB) is poorly understood. To gain insights into the growth and dissemination behavior of the MB tumor cells under treatment, we combined three-dimensional cell culture screening with ex vivo organotypic cerebellum slice co-culture (OCSC), which allowed the assessment of tumor cell behavior in the tissue context.

To identify druggable kinase pathways involved in invasion, we screened a panel of 274 kinase inhibitors and identified aurora kinase B (AURKB) as a potential anti-invasion drug target in MB. We validated tumor suppressive activities of the AURKB inhibitor (AURKBi) Barasertib (AZD1152-HQPA) and the structurally unrelated compound GSK-1070916 in cerebellum slice culture models for SHH, and Grp3 MB. Importantly, AURKBi are tumor suppressive in the tissue context, also in MB tumor cells that are in vitro resistant to the same treatment. We confirmed the requirement of AURKB for tumor growth and expansion in the tissue context through genetic suppression of AURKB by siRNA. We revealed that the combination of AURKBi with the SRC/BCR-ABL inhibitor Dasatinib acts synergistically to repress tumor growth and expansion in the highly invasive MB cell model ONS-76, but not in Grp3 MB cells. We demonstrate that tumor growth in the tissue context is suppressed by pharmacological inhibition of AURKB, comparable to the growth reduction observed after X-ray irradiation, which was used as the positive control. Finally, we show that exposure to µM concentrations of Barasertib does not cause developmental toxicity in fish larvae.

In conclusion, we demonstrate that AURKB is essential for MB tumor growth and expansion in the tissue context and the inhibition of AURKB is equally efficient as irradiation in repressing tumor cell growth. In patients younger than three years, pharmacological targeting of AURKB may thus constitute a novel means to overcome radiotherapy limitations.

Place, publisher, year, edition, pages
Elsevier, 2025
Keywords
Medulloblastoma, aurora kinase B, organotypic cerebellum slice culture, radiation therapy replacement, zebrafish larval model
National Category
Cell and Molecular Biology Cancer and Oncology
Identifiers
urn:nbn:se:uu:diva-544253 (URN)10.1016/j.neo.2024.101078 (DOI)001355250800001 ()39514961 (PubMedID)2-s2.0-85208172490 (Scopus ID)
Available from: 2024-12-03 Created: 2024-12-03 Last updated: 2024-12-03Bibliographically approved
Mazzaferro, E., Mujica, E., Zhang, H., Emmanouilidou, A., Jenseit, A., Evcimen, B., . . . den Hoed, M. (2025). Functionally characterizing obesity-susceptibility genes using CRISPR/Cas9, in vivo imaging and deep learning.. Scientific Reports, 15(1), 5408, Article ID 5408.
Open this publication in new window or tab >>Functionally characterizing obesity-susceptibility genes using CRISPR/Cas9, in vivo imaging and deep learning.
Show others...
2025 (English)In: Scientific Reports, E-ISSN 2045-2322, Vol. 15, no 1, p. 5408-, article id 5408Article in journal (Refereed) Published
Abstract [en]

Hundreds of loci have been robustly associated with obesity-related traits, but functional characterization of candidate genes remains a bottleneck. Aiming to systematically characterize candidate genes for a role in accumulation of lipids in adipocytes and other cardiometabolic traits, we developed a pipeline using CRISPR/Cas9, non-invasive, semi-automated fluorescence imaging and deep learning-based image analysis in live zebrafish larvae. Results from a dietary intervention show that 5 days of overfeeding is sufficient to increase the odds of lipid accumulation in adipocytes by 10 days post-fertilization (dpf, n = 275). However, subsequent experiments show that across 12 to 16 established obesity genes, 10 dpf is too early to detect an effect of CRISPR/Cas9-induced mutations on lipid accumulation in adipocytes (n = 1014), and effects on food intake at 8 dpf (n = 1127) are inconsistent with earlier results from mammals. Despite this, we observe effects of CRISPR/Cas9-induced mutations on ectopic accumulation of lipids in the vasculature (sh2b1 and sim1b) and liver (bdnf); as well as on body size (pcsk1, pomca, irs1); whole-body LDLc and/or total cholesterol content (irs2b and sh2b1); and pancreatic beta cell traits and/or glucose content (pcsk1, pomca, and sim1a). Taken together, our results illustrate that CRISPR/Cas9- and image-based experiments in zebrafish larvae can highlight direct effects of obesity genes on cardiometabolic traits, unconfounded by their - not yet apparent - effect on excess adiposity.

Place, publisher, year, edition, pages
Springer Nature, 2025
Keywords
CRISPR/Cas9, Deep learning, Fluorescence microscopy, Image analysis, Zebrafish
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:uu:diva-551246 (URN)10.1038/s41598-025-89823-2 (DOI)001421594200003 ()39948378 (PubMedID)
Available from: 2025-02-22 Created: 2025-02-22 Last updated: 2025-03-03Bibliographically approved
Jamialahmadi, O., Mujica, E., Morris, L., Mancina, R. M., Ciociola, E., Qadri, S. F., . . . Romeo, S. (2025). Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology, 31(4), 1252-1268
Open this publication in new window or tab >>Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease
Show others...
2025 (English)In: Clinical and Molecular Hepatology, ISSN 2287-2728, E-ISSN 2287-285X, Vol. 31, no 4, p. 1252-1268Article in journal (Refereed) Published
Abstract [en]

Background/Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) may progress to liver inflammation, fibrosis, cirrhosis and hepatocellular carcinoma. So far, genome-wide association studies explain a small fraction of MASLD heritability.

Methods: We sought to identify novel genetic determinants of MASLD by exploring interactions between genetic variants and body mass index (BMI). First, we examined genome-wide interactions with BMI for circulating alanine aminotransferase (ALT) levels using UK Biobank data. For identified loci, we next examined associations with hepatic proton density fat fraction (PDFF) in 35,146 independent UK Biobank participants. Associations with PDFF were replicated in four independent European cohorts, followed by a phenome-wide association study. Finally, we used human liver epigenomic maps and CRISPR/Cas9 experiments in vitro and in vivo to functionally characterize the CYP7A1 locus.

Results: Thirteen loci interact with BMI for ALT (P<5E-8), including eight well-known genetic modulators of MASLD. Two loci-UBXN2B/CYP7A1 and GIPR-are additionally associated with PDFF. For the intronic rs34783010 in GIPR, the minor T allele is associated with lower BMI and higher HbA1c and liver triglyceride content in humans. The UBXN2B/CYP7A1 locus is associated with PDFF in four additional European cohorts. Epigenomic data and in vitro experiments in human liver cells prioritise rs10504255 and CYP7A1 as the functional effectors in this locus. Perturbation of CYP7A1 orthologues using CRISPR/Cas 9 results in less liver fat in 10-day-old, metabolically challenged zebrafish larvae.

Conclusions: A genome-wide single nucleotide polymorphismxBMI design fuelled identification of two MASLD genes: CYP7A1 and GIPR.

Place, publisher, year, edition, pages
The Korean Association for the Study of the Liver, 2025
Keywords
Gene-environment interaction, Genome-wide association study, MASLD, Gastric inhibitory polypeptide receptor, CYP7A1
National Category
Medical Genetics and Genomics Gastroenterology and Hepatology
Identifiers
urn:nbn:se:uu:diva-572322 (URN)10.3350/cmh.2025.0159 (DOI)001619038300001 ()40452229 (PubMedID)2-s2.0-105021534396 (Scopus ID)
Funder
EU, Horizon 2020Knut and Alice Wallenberg FoundationSwedish Heart Lung FoundationSwedish Research CouncilEU, Horizon 2020Swedish Cancer Society
Available from: 2025-12-11 Created: 2025-12-11 Last updated: 2026-06-25Bibliographically approved
Al-Radi, O., Ingelshed, K., Eichhorn, L., Josefsson, H., Krkoska, M., Bräutigam, L., . . . Kannan, P. (2025). Pharmacological activation of p53 induces dose-dependent changes in endothelial cell fate during angiogenic sprouting. Cell Death and Disease, 16, Article ID 883.
Open this publication in new window or tab >>Pharmacological activation of p53 induces dose-dependent changes in endothelial cell fate during angiogenic sprouting
Show others...
2025 (English)In: Cell Death and Disease, E-ISSN 2041-4889, Vol. 16, article id 883Article in journal (Refereed) Published
Abstract [en]

The cell cycle is a key regulator of endothelial cell specification into tip and stalk cell phenotypes, which are essential for angiogenesis in both normal development and pathological conditions. While the tumor suppressor p53 is known to regulate the cell cycle and influence cell fate, its role in modulating the cell fate of these phenotypes remains unclear. Using non-genotoxic small molecule and stapled peptide compounds to pharmacologically activate p53 via MDM2 inhibition, we demonstrate that graded levels of p53 induce distinct cellular fates in normal endothelial cells. Low levels of p53 induce reversible cell cycle arrest by reducing DNA replication, while high levels induce senescence and cell death. Surprisingly, all tested levels of p53 activation reduced the growth of venous blood vessels in vitro and in zebrafish embryo models. This reduction in sprouting may stem from distinct cellular responses in tip-like and non-tip-like cells to pharmacological p53 activation: low p53 levels primarily reduced proliferation in non-tip-like cells, whereas high levels decreased the frequency of tip-like cells and the expression of genes associated with tip and stalk cell identities. Our findings show for the first time that pharmacological p53 activation modulates endothelial cell fate in a dose-dependent manner during sprouting angiogenesis. They also highlight the potential of using graded p53 modulation as a therapeutic strategy to target abnormal tip or stalk cell development in pathological angiogenesis, such as in cancer.

Place, publisher, year, edition, pages
Springer Nature, 2025
National Category
Cell and Molecular Biology Cancer and Oncology Developmental Biology
Identifiers
urn:nbn:se:uu:diva-575004 (URN)10.1038/s41419-025-08292-7 (DOI)001636246700001 ()41360924 (PubMedID)2-s2.0-105024712487 (Scopus ID)
Funder
EU, Horizon 2020, 839585Swedish Research Council, 2013-08807Gunvor och Josef Anérs stiftelse, FB23-0164Swedish Cancer Society, 22 0527 FE
Available from: 2026-01-12 Created: 2026-01-12 Last updated: 2026-01-12Bibliographically approved
Arnold, H., Panara, V., Allalou, A. & Koltowska, K. (2025). Protocol to computationally average confocal images of zebrafish lymphatic vessels to identify phenotypes. STAR Protocols, 6(1), Article ID 103632.
Open this publication in new window or tab >>Protocol to computationally average confocal images of zebrafish lymphatic vessels to identify phenotypes
2025 (English)In: STAR Protocols, E-ISSN 2666-1667, Vol. 6, no 1, article id 103632Article in journal (Refereed) Published
Abstract [en]

Characterization of zebrafish mutants is routinely time consuming as morphological phenotypes can be subtle or variable, thus hampering robust quantification. Here, we present a protocol to identify the overall phenotype by overlaying images of lymphatic vessels acquired from multiple zebrafish embryos of a genetic background. We describe steps for preparing samples, obtaining confocal images, and their computational alignment. In addition, we supply sample images for testing. For complete details on the use and execution of this protocol, please refer to Arnold et al.1

Place, publisher, year, edition, pages
Cell Press, 2025
Keywords
image, samples, obtaining, alignment, computational, images
National Category
Radiology and Medical Imaging Computer graphics and computer vision
Identifiers
urn:nbn:se:uu:diva-551740 (URN)10.1016/j.xpro.2025.103632 (DOI)001425140300001 ()39923241 (PubMedID)2-s2.0-85217081494 (Scopus ID)
Funder
Knut and Alice Wallenberg Foundation, 2017.0144Knut and Alice Wallenberg Foundation, 2024.0181Ragnar Söderbergs stiftelse, M13/17Swedish Research Council, 2016-01437Swedish Research Council, 2023-02459Kjell and Marta Beijer Foundation
Available from: 2025-03-26 Created: 2025-03-26 Last updated: 2025-03-26Bibliographically approved
Panara, V., Yu, H., Peng, D., Staxäng, K., Hodik, M., Gorniok, B. F., . . . Koltowska, K. (2024). Multiple cis-regulatory elements control prox1a expression in distinct lymphatic vascular beds. Development, 151(9), Article ID dev202525.
Open this publication in new window or tab >>Multiple cis-regulatory elements control prox1a expression in distinct lymphatic vascular beds
Show others...
2024 (English)In: Development, ISSN 0950-1991, E-ISSN 1477-9129, Vol. 151, no 9, article id dev202525Article in journal (Refereed) Published
Abstract [en]

During embryonic development, lymphatic endothelial cell (LEC) precursors are distinguished from blood endothelial cells by the expression of Prospero-related homeobox 1 (Prox1), which is essential for lymphatic vasculature formation in mouse and zebrafish. Prox1 expression initiation precedes LEC sprouting and migration, serving as the marker of specified LECs. Despite its crucial role in lymphatic development, Prox1 upstream regulation in LECs remains to be uncovered. SOX18 and COUP-TFII are thought to regulate Prox 1 in mice by binding its promoter region. However, the specific regulation of Prox1 expression in LECs remains to be studied in detail. Here, we used evolutionary conservation and chromatin accessibility to identify enhancers located in the proximity of zebrafish prox1a active in developing LECs. We confirmed the functional role of the identified sequences through CRISPR/Cas9 mutagenesis of a lymphatic valve enhancer. The deletion of this region results in impaired valve morphology and function. Overall, our results reveal an intricate control of prox1a expression through a collection of enhancers. Ray-finned fish-specific distal enhancers proximal enhancers refine expression in functionally distinct subsets of lymphatic endothelium.

Place, publisher, year, edition, pages
COMPANY BIOLOGISTS LTD, 2024
Keywords
Prox1, Enhancers, Evolutionary conservation, Gene, regulation, Lymphatic endothelial cell, Transcription factor, Zebrafish
National Category
Developmental Biology
Identifiers
urn:nbn:se:uu:diva-541033 (URN)10.1242/dev.202525 (DOI)001228417800004 ()38722096 (PubMedID)
Funder
Knut and Alice Wallenberg Foundation, 2017.0144Swedish Research Council, VR-MH-2016-01437
Available from: 2024-12-09 Created: 2024-12-09 Last updated: 2024-12-09Bibliographically approved
Habicher, J., Varshney, G. K., Waldmann, L., Snitting, D., Allalou, A., Zhang, H., . . . Ledin, J. (2022). Chondroitin/dermatan sulfate glycosyltransferase genes are essential for craniofacial development. PLOS Genetics, 18(2), Article ID e1010067.
Open this publication in new window or tab >>Chondroitin/dermatan sulfate glycosyltransferase genes are essential for craniofacial development
Show others...
2022 (English)In: PLOS Genetics, ISSN 1553-7390, E-ISSN 1553-7404, Vol. 18, no 2, article id e1010067Article in journal (Refereed) Published
Abstract [en]

Chondroitin/dermatan sulfate (CS/DS) proteoglycans are indispensable for animal development and homeostasis but the large number of enzymes involved in their biosynthesis have made CS/DS function a challenging problem to study genetically. In our study, we generated loss-of-function alleles in zebrafish genes encoding CS/DS biosynthetic enzymes and characterized the effect on development in single and double mutants. Homozygous mutants in chsy1, csgalnact1a, csgalnat2, chpfa, ust and chst7, respectively, develop to adults. However, csgalnact1a-/- fish develop distinct craniofacial defects while the chsy1-/- skeletal phenotype is milder and the remaining mutants display no gross morphological abnormalities. These results suggest a high redundancy for the CS/DS biosynthetic enzymes and to further reduce CS/DS biosynthesis we combined mutant alleles. The craniofacial phenotype is further enhanced in csgalnact1a-/-;chsy1-/- adults and csgalnact1a-/-;csgalnact2-/- larvae. While csgalnact1a-/-;csgalnact2-/- was the most affected allele combination in our study, CS/DS is still not completely abolished. Transcriptome analysis of chsy1-/-, csgalnact1a-/- and csgalnact1a-/-;csgalnact2-/- larvae revealed that the expression had changed in a similar way in the three mutant lines but no differential expression was found in any of fifty GAG biosynthesis enzymes identified. Thus, zebrafish larvae do not increase transcription of GAG biosynthesis genes as a consequence of decreased CS/DS biosynthesis. The new zebrafish lines develop phenotypes similar to clinical characteristics of several human congenital disorders making the mutants potentially useful to study disease mechanisms and treatment.

Place, publisher, year, edition, pages
Public Library of Science (PLoS), 2022
National Category
Biochemistry Molecular Biology
Identifiers
urn:nbn:se:uu:diva-473635 (URN)10.1371/journal.pgen.1010067 (DOI)001004241700001 ()35192612 (PubMedID)
Funder
Science for Life Laboratory, SciLifeLab
Note

Correction in: The PLOS Genetics, vol. 18, issue 5, Article no e1010242.

DOI: 10.1371/journal.pgen.1010242

Available from: 2022-04-29 Created: 2022-04-29 Last updated: 2025-02-20Bibliographically approved
Arnold, H., Panara, V., Hussmann, M., Gorniok, B. F., Skoczylas, R., Ranefall, P., . . . Koltowska, K. (2022). mafba and mafbb differentially regulate lymphatic endothelial cell migration in topographically distinct manners. Cell Reports, 39(12), Article ID 110982.
Open this publication in new window or tab >>mafba and mafbb differentially regulate lymphatic endothelial cell migration in topographically distinct manners
Show others...
2022 (English)In: Cell Reports, ISSN 2639-1856, E-ISSN 2211-1247, Vol. 39, no 12, article id 110982Article in journal (Refereed) Published
Abstract [en]

Lymphangiogenesis, formation of lymphatic vessels from pre-existing vessels, is a dynamic process that requires cell migration. Regardless of location, migrating lymphatic endothelial cell (LEC) progenitors probe their surroundings to form the lymphatic network. Lymphatic-development regulation requires the transcription factor MAFB in different species. Zebrafish Mafba, expressed in LEC progenitors, is essential for their migration in the trunk. However, the transcriptional mechanism that orchestrates LEC migration in different lymphatic endothelial beds remains elusive. Here, we uncover topographically different requirements of the two paralogs, Mafba and Mafbb, for LEC migration. Both mafba and mafbb are necessary for facial lymphatic development, but mafbb is dispensable for trunk lymphatic development. On the molecular level, we demonstrate a regulatory network where Vegfc-Vegfd-SoxF-Mafba-Mafbb is essential in facial lymphangiogenesis. We identify that mafba and mafbb tune the directionality of LEC migration and vessel morphogenesis that is ultimately necessary for lymphatic function.

Place, publisher, year, edition, pages
Elsevier, 2022
National Category
Cell and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-481695 (URN)10.1016/j.celrep.2022.110982 (DOI)000826780900003 ()35732122 (PubMedID)2-s2.0-85132621723 (Scopus ID)
Available from: 2022-08-16 Created: 2022-08-16 Last updated: 2025-08-28Bibliographically approved
Waldmann, L., Leyhr, J., Zhang, H., Allalou, A., Öhman, C. & Haitina, T. (2022). The Role of Gdf5 in the Development of the Zebrafish Fin Endoskeleton. Developmental Dynamics, 251(9), 1535-1549
Open this publication in new window or tab >>The Role of Gdf5 in the Development of the Zebrafish Fin Endoskeleton
Show others...
2022 (English)In: Developmental Dynamics, ISSN 1058-8388, E-ISSN 1097-0177, Vol. 251, no 9, p. 1535-1549Article in journal (Refereed) Published
Abstract [en]

The development of the vertebrate skeleton requires a complex interaction of multiple factors to facilitate correct shaping and positioning of bones and joints. Growth and differentiation factor 5 (Gdf5), a member of the transforming growth factor-beta family (TGF-beta) is involved in patterning appendicular skeletal elements including joints. Expression of gdf5 in zebrafish has been detected within the first pharyngeal arch jaw joint, fin mesenchyme condensations and segmentation zones in median fins, however little is known about the functional role of Gdf5 outside of Amniota. 

We generated CRISPR/Cas9 knockout of gdf5 in zebrafish and analysed the resulting phenotype at different developmental stages. Homozygous gdf5 mutant zebrafish display truncated median fin endoskeletal elements and loss of posterior radials in the pectoral fins. 

These findings are consistent with phenotypes observed in human and mouse appendicular skeleton in response to Gdf5 knockout, suggesting a broadly conserved role for Gdf5 in Osteichthyes.

Place, publisher, year, edition, pages
John Wiley & Sons, 2022
Keywords
gdf5, fin, joints, zebrafish, appendicular skeleton, CRISPR/Cas9 mutant
National Category
Developmental Biology
Identifiers
urn:nbn:se:uu:diva-430383 (URN)10.1002/dvdy.399 (DOI)000678743100001 ()
Funder
Swedish Research Council, 621-2012-4673Science for Life Laboratory, SciLifeLab
Available from: 2021-01-08 Created: 2021-01-08 Last updated: 2024-10-16Bibliographically approved
Waldmann, L., Leyhr, J., Zhang, H., Öhman, C., Allalou, A. & Haitina, T. (2021). The broad role of Nkx3.2 in the development of the zebrafish axial skeleton. PLOS ONE, 16(8), Article ID e0255953.
Open this publication in new window or tab >>The broad role of Nkx3.2 in the development of the zebrafish axial skeleton
Show others...
2021 (English)In: PLOS ONE, E-ISSN 1932-6203, Vol. 16, no 8, article id e0255953Article in journal (Refereed) Published
Abstract [en]

The transcription factor Nkx3.2 (Bapx1) is an important chondrocyte maturation inhibitor. Previous Nkx3.2 knockdown and overexpression studies in non-mammalian gnathostomes have focused on its role in primary jaw joint development, while the function of this gene in broader skeletal development is not fully described. We generated a mutant allele of nkx3.2 in zebrafish with CRISPR/Cas9 and applied a range of techniques to characterize skeletal phenotypes at developmental stages from larva to adult, revealing loss of the jaw joint, fusions in bones of the occiput, morphological changes in the Weberian apparatus, and the loss or deformation of bony elements derived from basiventral cartilages of the vertebrae. Axial phenotypes are reminiscent of Nkx3.2 knockout in mammals, suggesting that the function of this gene in axial skeletal development is ancestral to osteichthyans. Our results highlight the broad role of nkx3.2 in zebrafish skeletal development and its context-specific functions in different skeletal elements.

Place, publisher, year, edition, pages
Public Library of Science (PLoS)Public Library of Science (PLoS), 2021
National Category
Medical Genetics and Genomics
Identifiers
urn:nbn:se:uu:diva-455491 (URN)10.1371/journal.pone.0255953 (DOI)000686373300086 ()34411150 (PubMedID)
Funder
Swedish Research Council, 621-2012-4673
Available from: 2021-10-18 Created: 2021-10-18 Last updated: 2025-02-10Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0003-4028-8443

Search in DiVA

Show all publications